Events Insights

LNP Resources & Expertise

Events Insights

Streamline Targeted LNP Development to Improve Preclinical Translation

Bridging the Gap Between LNP Innovation and Clinical Success

Why NHP Models Remain Critical for LNP Development and How Envol Is Advancing Translational Confidence

From Design to Delivery: How Envol and the New LNP Alliance Is Solving the Biggest Bottlenecks in Genetic Medicine

Envol Biomedical is Proud to be the Expert NHP Partner in the Launch of the New LNP Alliance

Seeing Through the Fog: Using Cryo-TEM to Characterize LNPs During Formulation and Process Changes

Characterization of LNP Payload Distribution and Loading Percentage

NIS discusses how cryo-ET can be used to visualize the 3D architecture of complex nanoparticles

Derisk Therapeutic Nanoparticle Programs with Stage-Appropriate Analytical Method Development

High-Purity PEG Diacylglycerols for Lipid Nanoparticles | SUNBRIGHT® Series

Custom Lipid Synthesis for Pharmaceutical Applications

Biodegradable Lipid Nanoparticles for mRNA Delivery and Vaccines

Non-viral RNA Delivery with Biodegradable Lipids

Leveraging Advanced Drug Delivery Systems to Improve Clinical Viability

Optimizing Formulation,Process Design, and CMC to Achieve Target-Appropriate Biodistribution